Incentive

Controlled processes must be put in place for the manufacturing of packaging material for pharmaceutical products and great care must be taken during production due to the many different risks of contamination. Additionally the regulatory and statutory conformity of the products and processes is also of major importance. Verification that a company has the required systems in place to ensure Good Manufacturing Practice (GMP) is mandatory for primary packaging and a major advantage for secondary packaging. The requirements have been standardised in ISO 15378:2017 in order to eliminate any room for interpretation and to preclude the uncertainties which can arise through different understandings. The standard sets out what is required in respect of a quality management system and how the requirements apply to the design, manufacture and supply of packaging material for medicinal products.

Outcome

ISO 15378 guarantees that the measures are in place to ensure product safety, product quality, legal conformity, process optimisation and risk minimisation.

Target groups

Companies and organisations of all sizes which make packaging and packaging material for the pharmaceutical industry.

Validity

3 years - there is an annual audit to ensure that standards are being maintained and a recertification audit after three years.

Recognition

A certification in the accredited scope is only possible for primary packaging manufacturers. However, secondary packaging manufacturers can obtain a confirmation of compliance with the fundamentals of ISO 15378:2017.

Combinations

ISO 15378 contains the requirements set out in ISO 9001 (quality management) and is compatible with all other management system standards like ISO 14001 (environmental management) and ISO 45001 (Occupational Health and Safety Management), etc.